BlackRock, Inc. 13D and 13G filings for MacroGenics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | MACROGENICS INC MGNX | BlackRock, Inc. BLK | 1,813,695 2.900% | -3,591,806 (-66.45%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | MACROGENICS INC MGNX | BlackRock, Inc. BLK | 5,405,501 8.600% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Sale | 2024-09-30 | 13G | MACROGENICS INC MGNX | BlackRock, Inc. BLK | 5,405,501 8.600% | -734,848 (-11.97%) | Filing |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | MACROGENICS INC MGNX | BlackRock, Inc. BLK | 6,140,349 9.900% | 149,844 (+2.50%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | MACROGENICS INC MGNX | BlackRock, Inc. BLK | 5,990,505 9.700% | 795,672 (+15.32%) | Filing |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | MACROGENICS INC MGNX | BlackRock, Inc. BLK | 5,194,833 8.500% | -718,957 (-12.16%) | Filing |